Amyris Inc. in brief
Amyris Inc. is an unlisted company in the Chemicals industry, based in Emeryville, California, USA. It was founded in 2003. In the year to December 2022 it had sales of $270 M and a net loss of $529 M. It employs about 980 people.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Amyris Inc.
Amyris, Inc. manufactures ingredients made with synthetic biology and focused on the plant sugars into rare bioidentical molecules, essential ingredients and clean, effective everyday products. The headquarters is in USA.
Amyris company annual revenue is 269 million USD and annual net loss was -528 million USD for year ending December 2022.
Amyris Inc. timeline
- 2003
- 🏁· approximateFounded
- 2006
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2010
- ✎Renamed Amyris, Inc.Formerly Amyris Biotechnologies Inc.
- 🔔· approximateInitial public offering on Nasdaq as AMRS
- 2021
- 💰Record revenue of $342 millionFY2021, the highest of the 5 years on record.
Events of Amyris Inc. from Wikidata, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Amyris Inc.
- Acquisitions and changes
- No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026); its SEC filings show that it ended its SEC registration (Form 15) on 7 May 2024.
Market cap history
World rank over time
Rank in USA: #2,165 (Jan 2022) · #2,288 (Dec 2022) · #3,090 (Jul 2023)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin (TTM)
- -195.9%
- Operating margin
- -210.9%
- Return on equity
- —
- Liabilities / assets
- 156.7%
- Net debt
- $829M
- Revenue growth
- -21.1%
- R&D / revenue
- 40.8%
- Revenue per employee
- $275 K
- Profit per employee
- $-539 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2022 | $270M | -21.1% | $-569M | $-529M | -195.9% |
| Dec 2021 | $342M | +97.4% | $-178M | $-271M | -79.3% |
| Dec 2020 | $173M | +13.5% | $-123M | $-331M | -191.2% |
| Dec 2019 | $153M | +139.9% | $-122M | $-243M | -159.1% |
| Dec 2018 | $64M | -50.2% | $-137M | $-230M | -362.0% |
| Dec 2017 | $128M | +90.0% | $-56M | $-156M | -122.2% |
| Dec 2016 | $67M | +96.7% | $-96M | $-97M | -144.9% |
| Dec 2015 | $34M | — | $-149M | $-218M | -638.2% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2022 | $-526M | — | — | $-1.69 | — |
| Dec 2021 | $-181M | — | — | $-0.97 | — |
| Dec 2020 | $-176M | — | — | $-1.88 | — |
| Dec 2019 | $-157M | — | — | $-2.72 | — |
| Dec 2018 | $-109M | — | — | $-3.69 | — |
| Dec 2017 | $-101M | — | — | $-2.89 | — |
| Dec 2016 | $-82M | — | — | $-6.55 | — |
| Dec 2015 | $-85M | — | — | $-26.20 | — |
SEC filings
- May 7, 20248-KCurrent reportMaterial agreement · Agreement ended · New financial obligation · Unregistered share sale · Change in control · Directors or officers changed · Other events
- Apr 23, 20248-KCurrent reportRegulation FD disclosure
- Apr 8, 20248-KCurrent reportRegulation FD disclosure
- Feb 28, 20248-KCurrent reportRegulation FD disclosure
- Feb 9, 20248-KCurrent reportBankruptcy · Restructuring costs · Auditor change · Other events
- Jan 4, 20248-KCurrent reportMaterial agreement
- Dec 29, 20238-KCurrent reportMaterial agreement · Acquisition or disposal completed · Restructuring costs · Regulation FD disclosure
- Dec 27, 20238-KCurrent reportDirectors or officers changed
- Dec 13, 20238-KCurrent reportMaterial agreement · Regulation FD disclosure
- Nov 29, 20238-KCurrent reportRegulation FD disclosure
- Nov 22, 20238-KCurrent reportRegulation FD disclosure
- Nov 7, 20238-KCurrent reportRegulation FD disclosure
Official filings of Amyris Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $270 M
- Operating income
- $-569 M
- Net income
- $-529 M
For year ending December-2022 · source: SEC filing
Balance sheet
- Total assets
- $825 M
- Total liabilities
- $1.3 B
- Total equity
- $-489 M
As of December-2022
Insider trading at Amyris Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Frank KungDirector | Otherindirect | -6.80 M | — | — | 0 | Form 4 |
| filed | Julie WashingtonDirector | Other | -19,166 | — | — | 0 | Form 4 |
| filed | Hermanus KieftenbeldCFO AND INTERIM CEO | Other | -123,102 | — | — | 0 | Form 4 |
| filed | Steven Richard MillsDirector | Other | -27,088 | — | — | 0 | Form 4 |
| filed | Ana DutraDirector | Other | -10,950 | — | — | 0 | Form 4 |
| filed | Ryan PanchadsaramDirector | Other | -35,785 | — | — | 0 | Form 4 |
| filed | Barbara HagerDirector, 10% owner | Disposal to the company | -46,047 | — | — | 0 | Form 4 |
| filed | Lisa QiDirector | Other | -37,471 | — | — | 0 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Amyris Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Amyris Inc. scorecard#
Passes 2 of the 14 checks that could be worked out: strongest in growth (2 of 6), weakest in profitability (0 of 4). Fiscal year 2022.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth2 of 6
- ✗Revenue grew in the newest year-21.1%Revenue down 21.1% in fiscal 2022.
- ✓Revenue up more than 5% a year over three years20.9%20.9% a year over the three years to fiscal 2022.
- ✓Faster growth over three years than its peers' median20.9%20.9% a year against Chemicals's median of -2.9% (60 companies).
- ✗Earnings per share grew in the newest year-1.69 vs -0.97Diluted EPS -1.69 in fiscal 2022 against -0.97 the year before (report's currency).
- ✗Net income higher than five years earlier-$529 M-$529 M in fiscal 2022 against -$156 M in 2017.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2022.
Profitability0 of 4
- ✗Profitable in the newest year-$529 MNet income -$529 M in fiscal 2022.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2022.
- ✗Operating margin above its peers' median-210.8%-210.8% against Chemicals's median of 4.4% (73 companies).
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-210.8%-210.8% in fiscal 2022 against -79.9% in 2019.
Financial health0 of 3
- ✗Short-term assets cover short-term liabilities0.8×Current ratio 0.79 at the end of fiscal 2022.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-23.0×Operating income -23.0 times interest in fiscal 2022.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2022.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year15.9%Diluted shares up 15.9% in fiscal 2022.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Chemicals, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Amyris Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 | FY 2015to Dec 31, 2015 | FY 2014to Dec 31, 2014 | FY 2013to Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 270−21.1%100% | 342+97.4%100% | 173+13.5%100% | 153+140%100% | 64−50.2%100% | 128r143+90.0%100% | 67+96.7%100% | 34−21.1%100% | 43+5.2%100% | 41—100% | |
| Cost of revenue | 259+66.7%95.9% | 155+76.7%45.4% | 88+15.3%50.7% | 76+108%49.9% | 37−41.1%57.7% | 62r63+9.9%48.8% | 57+51.7%84.4% | 37+12.6%109% | 33−13.2%76.7% | 38—93.0% | |
| Research and development | 110+16.9%40.8% | 94+31.5%27.6% | 72+0.3%41.4% | 71+4.0%46.8% | 69+19.4%108% | 58r57+12.0%45.1% | 51+15.2%76.5% | 45−10.1%131% | 50−11.4%115% | 56—136% | |
| Selling, general and administrative | 494+91.5%183% | 258+88.1%75.4% | 137+8.3%79.2% | 127+39.3%83.0% | 91+42.4%143% | 64r63+33.8%50.0% | 48−15.2%71.0% | 56+1.5%165% | 55−2.8%128% | 57—139% | |
| Total costs and expenses | 839+61.5%311% | 519+75.2%152% | 297+8.1%171% | 274+37.1%180% | 200+9.0%315% | 184r183+12.6%144% | 163−10.7%243% | 183+27.7%535% | 143−11.0%331% | 161—391% | |
| Operating income | −569—−211% | −178—−52.0% | −123—−71.3% | −122—−79.9% | −137—−215% | −56r−40—−43.9% | −96—−143% | −149—−435% | −100—−231% | −120—−291% | |
| Interest and finance income | — | — | — | — | — | — | 0.3−2.3%0.4% | 0.3−31.8%0.8% | 0.4+139%0.9% | 0.2—0.4% | |
| Interest expense and finance costs | 25−3.4%9.2% | 26−46.6%7.5% | 48−18.3%27.7% | 59+37.4%38.5% | 43+15.2%67.1% | 37r34−1.5%29.0% | 38−52.3%56.0% | 79+172%231% | 29+218%66.9% | 9.1—22.1% | |
| Share of profit of associates | — | −7.6—−2.2% | −2.7—−1.6% | 0—0.0% | — | — | — | −4.2—−12.3% | −2.9r2.9—−6.7% | 0—0.0% | |
| Other non-operating income (expense) | 30—11.3% | −95—−27.7% | −200—−116% | −120—−78.8% | −94—−147% | −93r−33—−72.9% | −0.9—−1.3% | −65−162%−190% | 105r0.3—244% | −116r−2.6—−282% | |
| Income before tax | −539—−200% | −272r−279—−79.7% | −324r−331—−187% | −242—−159% | −230—−362% | −149r−72—−117% | −97—−144% | −213r−218−3930%−625% | 5.6—12.9% | −236—−573% | |
| Income tax | −2.7—−1.0% | −8.1−2869%−2.4% | 0.3−53.4%0.2% | 0.6—0.4% | 0−100%0.0% | 6.9r0.3+1144%5.4% | 0.6+18.2%0.8% | 0.5−5.5%1.4% | 0.5—1.1% | −0.8—−2.1% | |
| Net income including minority interests | −543—−201% | −272—−79.5% | −327—−189% | −243—−159% | — | −72—−56.7% | −97—−145% | −218−10162%−638% | 2.2—5.0% | −235—−571% | |
| Minority interests' share of net income | −15—−5.5% | −0.8−120%−0.2% | 4.2—2.4% | 0—0.0% | — | — | — | −0.1—−0.3% | −0.1−158%−0.3% | 0.2—0.5% | |
| Net income attributable to shareholders | −529—−196% | −271—−79.3% | −331—−191% | −243—−159% | −230—−362% | −156r−72—−122% | −97—−145% | −218−9634%−638% | 2.3—5.3% | −235—−572% | |
| Earnings per share, basic | -1.65—— | -0.93—— | -1.88—— | -2.67—— | -3.69—— | -2.89—— | -6.12r-0.41—— | -26.20r-1.75−87433%— | 0.03—— | -3.12—— | |
| Earnings per share, diluted | -1.69—— | -0.97—— | -1.88—— | -2.72—— | -3.69—— | -2.89—— | -6.55r-0.44—— | -26.20r-1.75—— | -0.90—— | -3.12—— | |
| Shares, weighted average (basic) | 321+9.7%— | 292+43.6%— | 204+101%— | 101+67.8%— | 60+87.3%— | 32+103%— | 16r238+87.8%— | 8.5r127−89.2%— | 78+3.9%— | 75—— | |
| Shares, weighted average (diluted) | 339+15.9%— | 293+43.7%— | 204+101%— | 101+67.7%— | 60+87.3%— | 32+82.8%— | 18r265+108%— | 8.5r127−93.1%— | 122+61.5%— | 75—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 64−86.7%7.8% | 483+1503%50.7% | 30r30+11067%13.5% | 0.3−99.4%0.2% | 45−20.5%35.5% | 57+110%40.5% | 27+126%20.9% | 12−71.5%11.3% | 42+512%19.4% | 6.9—3.5% | |
| Short-term investments | — | — | — | — | — | — | 1.4−9.6%1.1% | 1.5+10.5%1.4% | 1.4—0.6% | — | |
| Receivables | — | — | — | — | — | 24r34+73.7%17.2% | 14r13+249%10.8% | 4.0−53.9%3.8% | 8.7+12.3%4.0% | 7.7—3.9% | |
| Inventory | 112+49.0%13.6% | 75+75.1%7.9% | 43+54.3%19.2% | 28+186%17.3% | 9.7+79.2%7.6% | 5.4−13.0%3.8% | 6.2−42.9%4.8% | 11−25.0%10.3% | 15+33.2%6.7% | 11—5.5% | |
| Other current assets | 5.4+67.8%0.7% | 3.2+128%0.3% | 1.4−45.0%0.6% | 2.6r2.6+35.2%1.6% | 1.9r4.3+54.1%1.5% | 1.2r5.5−27.9%0.9% | 1.7−62.7%1.3% | 4.6r5.9−29.9%4.3% | 6.5−31.4%3.0% | 9.5—4.8% | |
| Current assets | 306−52.1%37.1% | 639+336%67.0% | 147+99.1%65.8% | 74−20.2%45.7% | 92−11.3%72.1% | 104r105+75.9%73.9% | 59+72.0%45.5% | 34r36−53.3%32.4% | 74+99.4%34.0% | 37—18.6% | |
| Property, plant and equipment | 182+150%22.1% | 73+122%7.6% | 33+13.6%14.8% | 29+46.4%18.0% | 20+42.2%15.4% | 14−74.1%9.9% | 54−10.1%41.4% | 60−49.7%56.4% | 119−15.4%55.0% | 141—70.7% | |
| Right-of-use (leased) assets | 97+200%11.8% | 32+220%3.4% | 10−23.2%4.5% | 13—8.2% | — | — | — | — | — | — | |
| Goodwill | 143+8.6%17.3% | 131—13.8% | 0—0.0% | 0—0.0% | — | 0.60.0%0.4% | 0.60.0%0.4% | 0.60.0%0.5% | 0.60.0%0.3% | 0.6—0.3% | |
| Other intangible assets | 47+19.5%5.7% | 39—4.1% | 0—0.0% | — | — | — | 0—0.0% | 0—0.0% | — | 9.1—4.6% | |
| Investments in associates | 3.0−68.2%0.4% | 9.4+297%1.0% | 2.4−49.7%1.1% | 4.7—2.9% | 0—0.0% | — | — | — | — | — | |
| Total assets | 825−13.6%100% | 954+328%100% | 223+38.4%100% | 161+25.8%100% | 128−9.1%100% | 141r151+8.4%100% | 130+22.4%100% | 106r110−50.9%100% | 216+8.7%100% | 199—100% | |
| Accounts payable | 190+139%23.1% | 80+94.1%8.3% | 41−19.9%18.4% | 51+90.9%31.8% | 27+73.0%21.0% | 16r16+1.3%11.0% | 15+92.8%11.8% | 7.9+128%7.5% | 3.5−46.4%1.6% | 6.5—3.3% | |
| Debt due within a year | 1.9+114%0.2% | 0.9−98.4%0.1% | 55+20.8%24.6% | 45−63.5%28.2% | 124+236%96.9% | 37+42.8%26.2% | 26−28.7%19.9% | 36r38+112%34.2% | 17+168%7.9% | 6.4—3.2% | |
| Current liabilities | 387+43.5%46.9% | 270+65.5%28.3% | 163+1.2%73.2% | 161−23.9%100% | 212+99.8%166% | 106r107−3.5%75.3% | 110+45.5%84.6% | 76r77+88.8%71.2% | 40+7.2%18.5% | 37—18.8% | |
| Long-term debt | 675+118%81.8% | 309+1081%32.4% | 26−46.0%11.7% | 48+11.8%30.1% | 43−28.0%33.9% | 60r62−53.2%42.8% | 129+76.7%99.1% | 73r75−27.2%68.7% | 100+78.2%46.3% | 56—28.2% | |
| Lease liabilities (non-current) | 86+335%10.4% | 20+104%2.1% | 9.7−35.3%4.4% | 15—9.3% | — | — | — | — | — | — | |
| Total liabilities | 1,293+91.5%157% | 675+73.2%70.7% | 390−5.2%175% | 411+21.0%255% | 340−3.7%266% | 353r346+14.4%251% | 308+16.6%237% | 265r269−22.5%249% | 341+2.0%158% | 335—168% | |
| Retained earnings | −2,880—−349% | −2,358—−247% | −2,087—−937% | −1,756—−1091% | −1,521—−1189% | −1,290r−1,207—−917% | −1,134—−873% | −1,037—−977% | −819—−379% | −821—−413% | |
| Shareholders' equity | −489−298%−59.2% | 246—25.8% | −177—−79.4% | −256—−159% | −218—−170% | −218r−201—−155% | −184—−142% | −158—−149% | −124—−57.6% | −135—−68.0% | |
| Minority interests | −13—−1.6% | −0.8−116%−0.1% | 4.8+684%2.1% | 0.6−35.0%0.4% | 0.90.0%0.7% | 0.90.0%0.7% | 0.9—0.7% | −0.4—−0.4% | −0.6—−0.3% | −0.6—−0.3% | |
| Total equity | −502−304%−60.8% | 246—25.7% | −172—−77.2% | −255—−159% | −217—−169% | −217r−200—−154% | −184—−141% | −158—−149% | −125—−57.9% | −136—−68.3% | |
| Total liabilities and equity | 825−13.6%100% | 954+328%100% | 223+38.4%100% | 161+25.8%100% | 128−9.1%100% | 141r151+8.4%100% | 130+22.4%100% | 106r110−50.9%100% | 216+8.7%100% | 199—100% | |
| Shares outstanding | 365+18.1%— | 309+26.1%— | 245+108%— | 118+53.8%— | 77+67.8%— | 46+150%— | 18r274−91.1%— | 206+160%— | 79+3.3%— | 77—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 12+41.5%4.6% | 8.7−6.7%2.6% | 9.4+105%5.4% | 4.6−6.9%3.0% | 4.9−56.7%7.7% | 11−0.1%8.9% | 11−12.0%16.9% | 13−13.7%37.8% | 15−10.0%34.6% | 17—40.5% | |
| Share-based compensation | 49+45.9%18.1% | 33+143%9.8% | 14+9.5%7.9% | 13+36.6%8.2% | 9.2+46.7%14.4% | 6.3−14.5%4.9% | 7.3−19.8%10.9% | 9.1−35.2%26.7% | 14−21.8%32.6% | 18—43.9% | |
| Cash from operating activities | −526—−195% | −181—−53.0% | −176—−102% | −157—−103% | −109—−172% | −101r−101—−79.2% | −82—−123% | −85—−249% | −85—−196% | −106—−257% | |
| Acquisitions, net of cash acquired | −18—−6.6% | −18—−5.4% | 0—0.0% | 0—0.0% | — | — | — | — | — | — | |
| Cash from investing activities | −124—−45.8% | −64—−18.8% | −13—−7.4% | −13—−8.6% | −12−124%−19.6% | 52r52+816%40.5% | 5.6—8.4% | −5.1—−15.1% | −9.8—−22.7% | −10—−25.1% | |
| Debt issued | 176−73.8%65.2% | 671+4202%196% | 16−91.8%9.0% | 189+100%124% | 94+399%148% | 19−70.4%14.8% | 64−4.5%95.1% | 67−19.5%196% | 83+689%192% | 11—25.6% | |
| Debt repaid | −0.8—−0.3% | −77—−22.5% | −52—−30.0% | −0.3r−112—−0.2% | −42—−65.5% | −38—−29.4% | −9.8—−14.5% | −41—−120% | −5.7—−13.2% | −3.3—−8.0% | |
| Shares issued | 0−100%0.0% | 131—38.3% | 0—0.0% | 0—0.0% | — | 5.8+3099%4.5% | 0.2−70.7%0.3% | 0.6−75.3%1.8% | 2.5+119%5.7% | 1.1r0.3—2.8% | |
| Cash from financing activities | 231−67.0%85.8% | 702+215%205% | 223+78.1%129% | 125+15.7%81.9% | 108+38.6%170% | 78r78−15.5%61.0% | 92+50.1%137% | 61−53.1%180% | 131+43.6%303% | 91—222% | |
| Exchange-rate effect on cash | 0.5+32.0%0.2% | 0.4—0.1% | −4.3—−2.5% | −0.3—−0.2% | −0.1−141%−0.1% | 0.2—0.1% | −0.3—−0.5% | −1.2—−3.5% | −1.2−193%−2.8% | 1.3—3.1% | |
| Change in cash | −418−191%−155% | 457+1437%134% | 30—17.2% | −45—−29.7% | −14−149%−21.9% | 29r30+88.5%22.4% | 15—22.6% | −30−185%−88.0% | 35—81.3% | −24—−57.7% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Mar 31, 2023 | Q1 FY2023to Mar 31, 2023 | Q4 FY2022to Dec 31, 2022 | Q3 FY2022to Sep 30, 2022 | Q2 FY2022to Jun 30, 2022 | Q1 FY2022to Mar 31, 2022 | Q4 FY2021to Dec 31, 2021 | Q3 FY2021to Sep 30, 2021 | Q2 FY2021to Jun 30, 2021 | Q1 FY2021to Mar 31, 2021 | Q4 FY2020to Dec 31, 2020 | Q3 FY2020to Sep 30, 2020 | Q2 FY2020to Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 268+20.5%100% | 56−2.8%100% | 76*+17.0%100% | 71+48.6%100% | 65+24.6%100% | 58−67.4%100% | 65*−18.8%100% | 48+39.7%100% | 52+74.4%100% | 177—100% | 80*—100% | 34—100% | 30—100% | |
| Cost of revenue | 261+43.7%97.2% | 51+4.3%91.1% | 88*+42.3%116% | 66+63.5%92.5% | 56+83.9%85.8% | 49+116%84.9% | 62*+128%95.4% | 40+55.9%84.1% | 30+31.7%58.1% | 23—12.8% | 27*—34.0% | 26—75.4% | 23—77.0% | |
| Research and development | 111+13.7%41.2% | 27+1.5%47.7% | 29*+17.2%38.2% | 29+20.8%40.5% | 26+16.4%40.0% | 26+13.0%45.7% | 25*+27.4%38.1% | 24+30.9%49.8% | 22+32.2%42.9% | 23—13.2% | 19*—24.3% | 18—53.1% | 17—56.5% | |
| Selling, general and administrative | 483+47.7%180% | 96−10.3%171% | 135*+42.7%179% | 125+76.6%175% | 127+133%194% | 107+182%185% | 95*+162%147% | 71+84.3%148% | 54+78.1%104% | 38—21.4% | 36*—45.4% | 38—112% | 31—102% | |
| Total costs and expenses | 898+45.4%335% | 242+32.6%431% | 229*+18.1%302% | 219+62.8%308% | 209+94.6%320% | 182+117%316% | 194*+134%299% | 135+63.6%281% | 107+51.9%205% | 84—47.4% | 83*—104% | 82—240% | 71—235% | |
| Operating income | −630—−235% | −186—−331% | −153*—−202% | −148—−208% | −143—−220% | −125−234%−216% | −129*—−199% | −87—−181% | −55—−105% | 93—52.6% | −3.0*—−3.7% | −48—−140% | −41—−135% | |
| Interest expense and finance costs | 32+29.5%12.1% | 13+147%23.1% | 7.9*−26.7%10.4% | 6.3+45.5%8.8% | 5.3+12.3%8.1% | 5.3−9.5%9.1% | 11*+73.2%16.6% | 4.3−34.8%9.0% | 4.7−76.5%9.0% | 5.8—3.3% | 6.2*—7.8% | 6.6—19.3% | 20—67.0% | |
| Other non-operating income (expense) | −1.0−100%−0.4% | −17−220%−30.5% | 0.8*−99.5%1.1% | −19−136%−26.6% | 34−52.2%52.4% | 14—24.8% | 164*—254% | 53+94.9%110% | 72—137% | −383—−217% | −105*—−131% | 27—79.0% | −67—−225% | |
| Income before tax | −631—−235% | −203—−361% | −152*−528%−201% | −167—−235% | −109−756%−168% | −110—−191% | 36r29*—54.8% | −34—−71.2% | 17—31.8% | −290—−164% | −108r−114*—−135% | −21—−61.3% | −108—−360% | |
| Income tax | −2.7—−1.0% | −0.9—−1.5% | −1.3*—−1.8% | 0.2+162%0.2% | −0.7−1302%−1.1% | −0.8−1591%−1.4% | −8.3*−41520%−12.8% | 0.1−30.1%0.1% | 0.1−42.4%0.1% | 0.1—0.0% | 0.0*—0.0% | 0.1—0.2% | 0.1—0.3% | |
| Net income including minority interests | −635—−237% | −202—−360% | −152*−512%−200% | −168—−236% | −114−835%−174% | −110—−191% | 37*—56.8% | −34—−71.0% | 15—29.5% | −290—−164% | −109*—−137% | −21—−62.6% | −108—−361% | |
| Minority interests' share of net income | −20—−7.6% | −8.4—−15.0% | −1.8*—−2.4% | −6.6—−9.3% | −3.5−5414%−5.4% | −2.9−344%−5.1% | −1.1*−401%−1.7% | −1.0−160%−2.1% | 0.1−96.9%0.1% | 1.2—0.7% | 0.4*—0.4% | 1.7—5.0% | 2.1—7.0% | |
| Net income attributable to shareholders | — | — | −150*−496%−198% | −161—−227% | −110−815%−169% | −107—−186% | 38*—58.4% | −33—−68.8% | 15—29.4% | −291—−165% | −110*—−137% | −23—−67.6% | −110—−368% | |
| Earnings per share, basic | — | -0.53—— | — | -0.50—— | -0.34−780%— | -0.34—— | — | -0.11—— | 0.05—— | -1.08—— | — | -0.37—— | -0.56—— | |
| Earnings per share, diluted | — | -0.53—— | — | -0.50—— | -0.44—— | -0.37—— | — | -0.27—— | -0.16—— | -1.08—— | — | -0.41—— | -0.56—— | |
| Shares, weighted average (basic) | 366+16.8%— | 366+16.8%— | — | 322+7.1%— | 320−0.1%— | 313+16.9%— | — | 301+32.4%— | 320+73.2%— | 268—— | — | 227—— | 185—— | |
| Shares, weighted average (diluted) | 366+12.9%— | 366+12.9%— | — | 322+1.5%— | 337−0.6%— | 324+20.9%— | — | 318+30.8%— | 339+83.3%— | 268—— | — | 243—— | 185—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 11—1.7% | 11−96.1%1.7% | 64−86.7%7.8% | 18−83.9%2.5% | 100−53.4%12.6% | 288+100%32.0% | 483+1503%50.7% | 115+200%21.2% | 214+114%48.1% | 144—44.0% | 30r30—13.5% | 38—18.6% | 100—37.4% | |
| Inventory | 109—16.0% | 109+32.5%16.0% | 112+49.0%13.6% | 129+79.5%17.2% | 99+82.8%12.6% | 82+72.7%9.2% | 75+75.1%7.9% | 72+93.7%13.3% | 54+64.1%12.2% | 48—14.6% | 43—19.2% | 37—18.1% | 33—12.3% | |
| Other current assets | 5.0—0.7% | 5.0+35.5%0.7% | 5.4+67.8%0.7% | 3.5+19.8%0.5% | 4.3+72.4%0.5% | 3.7+162%0.4% | 3.2+128%0.3% | 3.0−3.1%0.5% | 2.5−26.8%0.6% | 1.4—0.4% | 1.4—0.6% | 3.1—1.5% | 3.4—1.3% | |
| Current assets | 244—35.8% | 244−48.3%35.8% | 306−52.1%37.1% | 272−2.0%36.1% | 310−11.2%39.3% | 471+86.7%52.4% | 639+336%67.0% | 278+112%51.3% | 349+83.1%78.3% | 252—77.2% | 147—65.8% | 131—63.7% | 191—71.2% | |
| Property, plant and equipment | 190—27.9% | 190+51.4%27.9% | 182+150%22.1% | 170+220%22.5% | 151+260%19.1% | 125+292%13.9% | 73+122%7.6% | 53+78.3%9.8% | 42+53.2%9.4% | 32—9.8% | 33—14.8% | 30—14.5% | 27—10.2% | |
| Right-of-use (leased) assets | 101—14.8% | 101+70.9%14.8% | 97+200%11.8% | 88+705%11.7% | 90+830%11.4% | 59+531%6.6% | 32+220%3.4% | 11+0.8%2.0% | 9.7−16.9%2.2% | 9.3—2.9% | 10—4.5% | 11—5.3% | 12—4.4% | |
| Goodwill | 50—7.4% | 50−62.9%7.4% | 143+8.6%17.3% | 127−1.6%16.8% | 134+3243%17.0% | 136—15.1% | 131—13.8% | 129—23.7% | 4.0—0.9% | — | 0—0.0% | — | — | |
| Other intangible assets | 45—6.6% | 45−19.7%6.6% | 47+19.5%5.7% | 55+37.8%7.2% | 58+623%7.3% | 56—6.2% | 39—4.1% | 40—7.3% | 8.0—1.8% | — | 0—0.0% | — | — | |
| Investments in associates | 3.0—0.4% | 3.0−68.9%0.4% | 3.0−68.2%0.4% | 3.9+59.1%0.5% | 4.7+104%0.6% | 9.7+181%1.1% | 9.4+297%1.0% | 2.5−39.0%0.5% | 2.3−43.3%0.5% | 3.4—1.1% | 2.4—1.1% | 4.1—2.0% | 4.0—1.5% | |
| Total assets | 680—100% | 680−24.3%100% | 825−13.6%100% | 754+39.0%100% | 789+77.1%100% | 898+175%100% | 954+328%100% | 542+163%100% | 446+66.5%100% | 327—100% | 223—100% | 206—100% | 268—100% | |
| Accounts payable | 200—29.4% | 200+127%29.4% | 190+139%23.1% | 134+65.9%17.7% | 103+112%13.0% | 88+100.0%9.8% | 80+94.1%8.3% | 81+166%14.9% | 49+113%10.9% | 44—13.5% | 41—18.4% | 30—14.7% | 23—8.5% | |
| Debt due within a year | 2.0—0.3% | 2.0+86.5%0.3% | 1.9+114%0.2% | 1.7−93.0%0.2% | 1.0−16.4%0.1% | 1.1−98.1%0.1% | 0.9−98.4%0.1% | 25−21.7%4.5% | 1.1−97.4%0.3% | 56—17.1% | 55—24.6% | 31—15.3% | 43—16.2% | |
| Current liabilities | 471—69.3% | 471+76.8%69.3% | 387+43.5%46.9% | 309−32.8%41.0% | 187+97.3%23.7% | 266+81.0%29.6% | 270+65.5%28.3% | 460+344%84.8% | 95−26.5%21.3% | 147—45.0% | 163—73.2% | 104—50.3% | 129—48.2% | |
| Long-term debt | 676—99.4% | 676+0.6%99.4% | 675+118%81.8% | 674+5470%89.4% | 673+4764%85.2% | 672+4744%74.8% | 309+1081%32.4% | 12−53.8%2.2% | 14−41.2%3.1% | 14—4.2% | 26—11.7% | 26—12.7% | 24—8.8% | |
| Lease liabilities (non-current) | 91—13.4% | 91+146%13.4% | 86+335%10.4% | 76+883%10.1% | 75+857%9.5% | 37+351%4.1% | 20+104%2.1% | 7.7−30.5%1.4% | 7.9−36.8%1.8% | 8.2—2.5% | 9.7—4.4% | 11—5.4% | 12—4.7% | |
| Total liabilities | 1,328—195% | 1,328+29.6%195% | 1,293+91.5%157% | 1,159+94.6%154% | 1,033+95.5%131% | 1,024+60.9%114% | 675+73.2%70.7% | 596+109%110% | 528+61.4%119% | 637—195% | 390—175% | 285—138% | 327—122% | |
| Retained earnings | −3,074—−452% | −3,074—−452% | −2,880—−349% | −2,730—−362% | −2,569—−325% | −2,459—−274% | −2,358—−247% | −2,396—−442% | −2,363—−530% | −2,378—−728% | −2,087—−937% | −1,977—−960% | −1,954—−730% | |
| Shareholders' equity | −664—−97.7% | −664—−97.7% | −489−298%−59.2% | −428—−56.7% | −273—−34.6% | −159—−17.7% | 246—25.8% | −89—−16.4% | −122—−27.4% | −321—−98.3% | −177—−79.4% | −88—−42.8% | −67—−25.2% | |
| Minority interests | −9.8—−1.4% | −9.8—−1.4% | −13—−1.6% | −13−664%−1.7% | −6.6−209%−0.8% | −3.5−159%−0.4% | −0.8−116%−0.1% | 2.3−47.4%0.4% | 6.0+122%1.4% | 6.0—1.8% | 4.8—2.1% | 4.4—2.1% | 2.7—1.0% | |
| Total equity | −674—−99.2% | −674—−99.2% | −502−304%−60.8% | −441—−58.4% | −280—−35.4% | −162—−18.1% | 246—25.7% | −87—−16.0% | −116—−26.0% | −315—−96.5% | −172—−77.2% | −84—−40.7% | −65—−24.1% | |
| Total liabilities and equity | 680—100% | 680−24.3%100% | 825−13.6%100% | 754+39.0%100% | 789+77.1%100% | 898+175%100% | 954+328%100% | 542+163%100% | 446+66.5%100% | 327—100% | 223—100% | 206—100% | 268—100% | |
| Shares outstanding | 369—— | 369+19.3%— | 365+18.1%— | 325+32.6%— | 321+31.1%— | 309+26.1%— | 309+26.1%— | 245+2.4%— | 245+19.7%— | 245—— | 245—— | 239—— | 205—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 14+60.5%5.4% | 4.5+88.6%8.1% | 4.2*+89.0%5.5% | 3.2+43.4%4.5% | 2.6+18.3%4.0% | 2.4+13.5%4.2% | 2.2*−15.7%3.4% | 2.2+16.9%4.7% | 2.2+30.4%4.2% | 2.1—1.2% | 2.6*—3.3% | 1.9—5.6% | 1.7r1.7—5.6% | |
| Share-based compensation | 43+5.6%16.0% | 5.8−50.1%10.3% | 12*+6.6%16.1% | 12+38.2%17.3% | 13+44.6%19.4% | 12+171%20.1% | 11*+196%17.7% | 8.9+160%18.6% | 8.7+198%16.7% | 4.3—2.4% | 3.9*—4.9% | 3.4—10.0% | 2.9—9.8% | |
| Cash from operating activities | −463—−173% | −90—−160% | −93*—−123% | −134*—−188% | −147*—−225% | −152−240%−264% | −142*—−219% | −69*—−145% | −78*—−150% | 109—61.4% | −9.9*—−12.5% | −55*—−162% | −64*—−213% | |
| Acquisitions, net of cash acquired | −4.2—−1.6% | 0—0.0% | 0*—0.0% | 0*—0.0% | −4.2*—−6.5% | −14—−23.5% | 0*—0.0% | −18*—−38.0% | −0.3*—−0.6% | 0—0.0% | 0*—0.0% | 0*—0.0% | — | |
| Cash from investing activities | −81—−30.3% | −4.8—−8.6% | −4.4*—−5.8% | −30*—−42.3% | −42*—−64.3% | −47—−81.9% | −24*—−36.3% | −35*—−72.9% | −3.2*—−6.1% | −2.5—−1.4% | −3.2*—−4.0% | −4.1*—−12.0% | −4.5*—−14.8% | |
| Debt issued | — | 37—65.9% | 95*−85.8%126% | — | — | 0—0.0% | 671*+209595%1036% | 0*—0.0% | 0*−100%0.0% | 0—0.0% | 0.3r−154*—0.4% | 0r0.0*—0.0% | 15r160*—50.3% | |
| Debt repaid | — | — | −0.8*—−1.1% | 0*—0.0% | 0*—0.0% | 0—0.0% | −51*—−78.8% | −2.5*—−5.3% | −0.2*—−0.4% | −23—−13.1% | −5.2*—−6.5% | −0.8*—−2.4% | −39*—−130% | |
| Shares issued | — | — | 0*—0.0% | 0*—0.0% | — | — | 0*—0.0% | 0*—0.0% | — | — | 0*—0.0% | 0*—0.0% | — | |
| Cash from financing activities | 269−61.5%100% | 42+951%74.2% | 143*−73.4%189% | 81*+1588%114% | 3.3*−97.8%5.0% | 4.0−47.4%6.9% | 538*+5755%830% | 4.8*—10.1% | 152*−8.4%290% | 7.5—4.3% | 9.2*—11.5% | −1.9*—−5.7% | 166*—552% | |
| Exchange-rate effect on cash | 0.4−37.1%0.1% | 0.1−67.5%0.1% | 0.3*—0.4% | 0.4*—0.6% | −0.5*−194%−0.7% | 0.2—0.3% | −0.0*—−0.1% | −0.0*—−0.1% | 0.5*+243%0.9% | −0.0—−0.0% | −4.2*—−5.3% | −0.2*—−0.6% | 0.1*—0.5% | |
| Change in cash | −275−286%−103% | −53—−94.8% | 46*−87.7%60.6% | −82*—−115% | −186*−364%−286% | −196−272%−339% | 372*—575% | −100*—−208% | 71*−27.5%135% | 114—64.3% | −8.1*—−10.2% | −62*—−180% | 97*—324% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Mar 31, 2023. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Events at Amyris Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Bankruptcy or receivershipAuditor changedFiling
Bankruptcy or receivership 2 · Delisting notice 3 · Auditor changed 1 · Debt called early 1 · Restructuring 3 · Change in control 1 · Acquisition or sale completed 2 · Directors and officers 9 · Material agreement 17 · Agreement ended 1 · New debt 4 · Unregistered share sale 2 · Shareholder rights changed 2 · Shareholder vote 1 · Results announced 3
| Filed | What happened | Filing |
|---|---|---|
| Change in controlDirectors and officersMaterial agreementAgreement endedNew debtUnregistered share saleShareholder rights changed | 8-K | |
| Bankruptcy or receivershipAuditor changedRestructuringShareholder rights changed | 8-K | |
| Material agreement | 8-K | |
| RestructuringAcquisition or sale completedMaterial agreement | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Material agreement | 8-K | |
| Material agreement | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Delisting notice | 8-K | |
| Bankruptcy or receivershipDebt called earlyRestructuringDirectors and officersMaterial agreementNew debt | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Delisting noticeDirectors and officers | 8-K | |
| Material agreement | 8-K | |
| Delisting noticeShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Acquisition or sale completed | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreement | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Material agreementNew debt | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of May 7, 2024
Acquisitions and funding#
35 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2022 | $8 M | No. 35 | $2 to $10 million | 1 | equity, options | SEC |
| Jun 2020 | $200 M | No. 34 | $50 to $250 million | 53 | equity | SEC |
| Jan 2020 | $94 M | No. 33 | $50 to $250 million | 7 | equity, options | SEC |
| Jan 2020 | $10 M | No. 32 | $2 to $10 million | 4 | equity, options | SEC |
| Nov 2019 | $4 M | No. 31 | $2 to $10 million | 1 | equity, options | SEC |
| Nov 2019 | $8 M | No. 30 | $2 to $10 million | 2 | equity, options | SEC |
| Oct 2019 | $8 M | No. 29 | $2 to $10 million | 1 | equity, options | SEC |
| Oct 2019 | $6 M | No. 28 | $2 to $10 million | 1 | equity, options | SEC |
| Sep 2019 | $13 M | No. 27 | $10 to $50 million | 3 | equity, options | SEC |
| Aug 2019 | $19 M | No. 26 | $10 to $50 million | 1 | equity, options | SEC |
| Aug 2019 | $10 M | No. 25 | $2 to $10 million | 2 | equity, options | SEC |
| Apr 2019 | $75 M | No. 24 | $50 to $250 million | 9 | equity, options | SEC |
| Apr 2019 | $36 M | No. 23 | $10 to $50 million | 1 | equity, options | SEC |
| Dec 2018 | $60 M | No. 22 | $50 to $250 million | 2 | equity, debt, options | SEC |
| Nov 2018 | $7 M | No. 21 | $2 to $10 million | 1 | equity | SEC |
| Aug 2018 | $91 M | No. 20 | $50 to $250 million | 3 | equity, options | SEC |
| Apr 2018 | $38 M | No. 19 | $10 to $50 million | 11 | equity, options | SEC |
| Aug 2017 | $25 M | No. 18 | $10 to $50 million | 1 | equity, options | SEC |
| May 2017 | $6 M | No. 17 | $2 to $10 million | 1 | equity, options | SEC |
| May 2017 | $65 M | No. 16 | $50 to $250 million | 22 | equity, options | SEC |
| Nov 2016 | $6 M | No. 15 | $2 to $10 million | 1 | equity, options | SEC |
| Aug 2016 | $3 M | No. 14 | $2 to $10 million | 1 | equity, options | SEC |
| May 2016 | $5 M | No. 13 | $2 to $10 million | 1 | equity | SEC |
| Feb 2016 | $20 M | No. 12 | $10 to $50 million | 3 | debt, options | SEC |
| Jul 2015 | $141 M | No. 11 | $50 to $250 million | 2 | equity | SEC |
| Apr 2014 | $4 M | No. 10 | $2 to $10 million | 1 | equity | SEC |
| Mar 2013 | $5 M | No. 9 | $2 to $10 million | 1 | equity | SEC |
| Dec 2012 | $42 M | No. 8 | $10 to $50 million | 7 | equity | SEC |
| May 2012 | $4 M | No. 7 | $2 to $10 million | 5 | equity | SEC |
| Feb 2012 | $59 M | No. 6 | $50 to $250 million | 6 | equity | SEC |
| Oct 2011 | $7 M | Issued in a merger or acquisition | $2 to $10 million | 1 | equity | SEC |
| Sep 2010 | $14 M | No. 5 | $10 to $50 million | 3 | equity | SEC |
| Jun 2010 | $133 M | No. 4 | $50 to $250 million | 1 | equity | SEC |
| Mar 2010 | $48 M | No. 3 | $10 to $50 million | 1 | equity | SEC |
| Jul 2009 | $61 M | No. 2 | $50 to $250 million | 34 | equity | SEC |
| Feb 2008 | $2 M | No. 1 | $2 to $10 million | 3 | options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Amyris Inc.#
4 labor condition applications certified in fiscal 2026 for 4 positions, at a median wage of $141 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| ScientistChemical Engineers | 2 | $150 K |
| Scientist 1Chemists | 1 | $131 K |
| Scientist 2, Analytical ChemistryChemists | 1 | $125 K |
Where: Emeryville, CA 4
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 4 | 4 | $141 K | 4 |
| FY2025 | 9 | 9 | $101 K | 10 |
| FY2024 | 10 | 10 | $105 K | 11 |
| FY2023 | 15 | 15 | $117 K | 16 |
| FY2022 | 31 | 31 | $119 K | 31 |
| FY2021 | 8 | 8 | $96 K | 9 |
| FY2020 | 7 | 7 | $119 K | 8 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Amyris, Inc.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | · | 80 | · | · | · | · | · | · | · | 50 | · | · | 130 |
| 2023 | · | · | · | · | · | 65 | · | 260 | · | 112 | · | 220 | 657 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| effective | 50 people | LayoffWARN notice | Emeryville, California | Notice list |
| 80 people | Restructuring planSEC 8-K | “On February 7, 2024, the Company announced the termination or separation of approximately 80 employees, effective February 7, 2024.” | Filing | |
| 220 people | Restructuring planSEC 8-K | “Item 2.05 Costs Associated With Exit or Disposal Activities In connection with the sale of certain consumer brands, the Company announced the termination or separation of approxima…” | Filing | |
| effective | 89 people | LayoffWARN notice | Emeryville, California | Notice list |
| effective | 112 people | LayoffWARN notice | Emeryville, California | Notice list |
| effective | 62 people | LayoffWARN notice | Alameda County, California | Notice list |
Source: State WARN notices and SEC 8-K item 2.05
How Amyris Inc. compares in Chemicals
- Revenue$270 M · higher than 17% of 421
- Net margin-195.8% · higher than 1% of 409
- Revenue growth-21.1% · higher than 13% of 111
Peer comparison · Chemicals
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Amyris Inc.🇺🇸 | $332 M | — | -195.8% | -21.1% |
| Linde plc🇬🇧 | $231.0 B | 33.0× | 19.3% | +3.0% |
| Air Liquide🇫🇷 | $124.8 B | 29.9× | 13.1% | +3.8% |
| The Sherwin-Williams Company🇺🇸 | $81.4 B | 30.4× | 10.7% | +2.1% |
| Ecolab Inc.🇺🇸 | $79.7 B | 38.3× | 12.0% | +2.2% |
| Shin-Etsu Chemical Co., Ltd.🇯🇵 | $74.3 B | 23.1× | 18.4% | — |
| Air Products and Chemicals, Inc.🇺🇸 | $66.5 B | — | -0.4% | -0.5% |
| Nan Ya Plastics Corporation🇹🇼 | $55.1 B | 372.9× | 1.7% | — |
| BASF SE🇩🇪 | $52.7 B | 27.4× | 2.7% | -18.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Linde plc$231.0 B
- Air Liquide$124.8 B
- The Sherwin-Williams Company$81.4 B
- Ecolab Inc.$79.7 B
- Shin-Etsu Chemical Co., Ltd.$74.3 B
- Air Products and Chemicals, Inc.$66.5 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- For year ending December-2022
- Balance sheet:
- As of December-2022
- Employees:
- As on 2021
- Profile updated:
- Nov 16, 2026
Figures from SEC filing, value.today research, Wikidata, Wikimedia Commons; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Amyris Inc.? Verify and update this profile — free
Show Amyris Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.